We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$9.85B
1-Year Est. Return
55.6%
This Fund
S&P 500
This Quarter
Est. Return
-0.27%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$15.2B
AUM Growth
+$771M
(+5.3%)
Cap. Flow
+$436M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
51.67%
Holding
1,265
New
318
Increased
300
Reduced
316
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.29B |
| 2 |
XL
XL Group Ltd.
XL
|
+$167M |
| 3 |
CAVM
Cavium, Inc.
CAVM
|
+$93.7M |
| 4 |
AET
Aetna Inc
AET
|
+$73.5M |
| 5 |
Petrobras Class A
PBR.A
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DST
DST Systems Inc.
DST
|
+$243M |
| 2 |
OA
Orbital ATK, Inc.
OA
|
+$217M |
| 3 |
AABA
Altaba Inc
AABA
|
+$130M |
| 4 |
HRG
HRG Group, Inc.
HRG
|
+$57.5M |
| 5 |
MDR
McDermott International
MDR
|
+$57.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 8.39% |
| 4 | Consumer Discretionary | 3.95% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
276
DELISTED
Blueprint Medicines
BPMC
| $4.67M | 0.03% |
73,585
+60,429
| +459% | +$4.81M |
|
277
Vipshop
VIPS
$7.53B
| $4.66M | 0.03% |
+429,680
| New | +$5.88M |
|
278
Enviri
NVRI
$620M
| $4.66M | 0.03% |
210,800
-10,539
| -5% | -$243K |
|
279
Green Dot
GDOT
$745M
| $4.66M | 0.03% |
63,463
-78,045
| -55% | -$5.38M |
|
280
Sony
SONY
$138B
| $4.63M | 0.03% |
451,230
+97,955
| +28% | +$953K |
|
281
Progress Software
PRGS
$1.76B
| $4.58M | 0.03% |
118,077
-118,423
| -50% | -$4.5M |
|
282
Stellantis
STLA
$20.8B
| $4.55M | 0.03% |
241,000
+219,638
| +1,028% | +$4.81M |
|
283
Hilton Grand Vacations
HGV
$3.55B
| $4.54M | 0.03% |
130,861
-33,147
| -20% | -$1.34M |
|
|
CNR
284
Core Natural Resources Inc
CNR
$4.45B
| $4.44M | 0.03% |
115,825
+32,146
| +38% | +$1.24M |
|
285
C.H. Robinson
CHRW
$17.5B
| $4.38M | 0.03% |
+52,300
| New | +$4.67M |
|
|
AJRD
286
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $4.37M | 0.03% |
148,109
-131,928
| -47% | -$3.81M |
|
|
TECD
287
DELISTED
Tech Data Corp
TECD
| $4.35M | 0.03% |
+52,959
| New | +$4.36M |
|
288
PVH
PVH
$4.04B
| $4.32M | 0.03% |
28,829
+7,429
| +35% | +$1.17M |
|
289
CALL
Exelixis
EXEL
$13.4B
| $4.3M | 0.03% |
200,000
| – | – |
|
290
Groupon
GRPN
$1.02B
| $4.3M | 0.03% |
50,025
+18,479
| +59% | +$1.71M |
|
291
PNC Financial Services
PNC
$101B
| $4.26M | 0.03% |
+31,537
| New | +$4.6M |
|
292
Jabil
JBL
$35.8B
| $4.25M | 0.03% |
153,693
-493,207
| -76% | -$13.9M |
|
|
HDP
293
DELISTED
Hortonworks, Inc.
HDP
| $4.25M | 0.03% |
233,053
+129,612
| +125% | +$2.33M |
|
294
AstraZeneca
AZN
$250B
| $4.18M | 0.03% |
+59,550
| New | +$4.28M |
|
|
CRC
295
DELISTED
California Resources Corporation
CRC
| $4.16M | 0.03% |
91,641
-59,209
| -39% | -$1.87M |
|
|
HZNP
296
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.11M | 0.03% |
247,900
-98,224
| -28% | -$1.5M |
|
297
CALL
TotalEnergies
TTE
$190B
| $4.09M | 0.03% |
6,184,688
+54,975
| +0.9% | +$36.8K |
|
298
M&T Bank
MTB
$36.2B
| $4.05M | 0.03% |
+23,800
| New | +$4.27M |
|
|
ARRY
299
DELISTED
Array Biopharma Inc
ARRY
| $4.05M | 0.03% |
241,106
-9,621
| -4% | -$153K |
|
300
Virgin Galactic
SPCE
$398M
| $4.02M | 0.03% |
20,000
| – | – |
|
Similar funds
MF
MPI
URS
CCM
HRCM
FCM
HL
DCP
HBK Investments's Q2 2018 Portfolio in Review
As of Q2 2018, HBK Investments held 1,265 positions worth $15.2B, up 5.3% from $14.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
HBK Investments's Q2 2018 filing shows 318 new, 300 increased, 316 reduced and 276 closed positions. Its largest new stake was Celgene Corp: 15,550,600 shares worth $1.44B. The largest sale was DST Systems Inc., an estimated $243M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- HBK Investments's largest Q2 2018 buy was Celgene Corp: 15,550,600 shares worth $1.44B.
- HBK Investments added most to XL Group Ltd. in Q2 2018, an estimated $167M increase.
- HBK Investments's biggest Q2 2018 reduction was Altaba Inc, cutting an estimated $130M.
- HBK Investments fully exited DST Systems Inc. in Q2 2018, selling an estimated $243M.
- HBK Investments's ten largest holdings make up 52% of its $15.2B portfolio in Q2 2018.
- HBK Investments opened 318 new positions and closed 276 in Q2 2018.
- HBK Investments's portfolio value rose 5.3% quarter-over-quarter to $15.2B.
Based on HBK Investments's 13F filing for Q2 2018, filed 14 Aug 2018.